<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05085756</url>
  </required_header>
  <id_info>
    <org_study_id>2021-03599</org_study_id>
    <nct_id>NCT05085756</nct_id>
  </id_info>
  <brief_title>Transdiagnostic Internet Intervention to Improve Mental Health Among University Students: Research Protocol for a Randomized Controlled Trial</brief_title>
  <acronym>Puma RCT</acronym>
  <official_title>Swedish Partnership in the WHO-World Mental Health International College Student (WMH-ICS) Study on National Mapping and E-health Interventions for Mental Health Issues Among University Students: Psychological Internet Treatment for Improved Mental Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Malmö University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stockholm University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will offer transdiagnostic CBT-based treatment for symptoms of depression and&#xD;
      anxiety to university students who have previously responded to the WHO-WMH-ICS survey.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 18, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PHQ-9 for depression</measure>
    <time_frame>last 2 weeks</time_frame>
    <description>9 items measuring depressive symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>GAD-7 for anxiety</measure>
    <time_frame>last 2 weeks</time_frame>
    <description>7 items measuring anxiety symptoms</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Psychological Disorder</condition>
  <arm_group>
    <arm_group_label>Guided treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8-week transdiagnostic CBT with written guidance from M.Sc-level students under supervision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unguided treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8-week transdiagnostic CBT without guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>8-week transdiagnostic CBT without guidance, made available 6 months after recruitment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Puma</intervention_name>
    <description>One psychoeducation module followed by two transdiagnostic modules tailored to primary depression or anxiety symptoms, followed by three participant-choice modules, and ending with two transdiagnostic modules.</description>
    <arm_group_label>Guided treatment</arm_group_label>
    <arm_group_label>Unguided treatment</arm_group_label>
    <arm_group_label>Waitlist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  PHQ-9 cutoff for mild depression&#xD;
&#xD;
          -  GAD-7 cutoff for mild anxiety&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Suicidal ideation or plans&#xD;
&#xD;
          -  Severe levels of mental ill-health&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Andersson C, Bendtsen M, Lindfors P, Molander O, Lindner P, Topooco N, Engström K, Berman AH. Does the management of personal integrity information lead to differing participation rates and response patterns in mental health surveys with young adults? A three-armed methodological experiment. Int J Methods Psychiatr Res. 2021 Aug 21:e1891. doi: 10.1002/mpr.1891. [Epub ahead of print]</citation>
    <PMID>34418224</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uppsala University</investigator_affiliation>
    <investigator_full_name>Anne H Berman</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This is a future plan. Outcome data will be shared as appropriate, but primarily within the WHO-WMH-ICS consortium.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

